Evercore ISI Begins Coverage on Xenon Pharmaceuticals (NASDAQ:XENE)
Evercore ISI initiated coverage on shares of Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) in a report published on Wednesday, MarketBeat reports. The brokerage issued an outperform rating and a $55.00 target price on the biopharmaceutical company’s stock. A number of other equities research analysts have also issued reports on the stock. Wells Fargo & Company […]
Evercore ISI initiated coverage on shares of Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) in a report published on Wednesday, MarketBeat reports. The brokerage issued an outperform rating and a $55.00 target price on the biopharmaceutical company’s stock. A number of other equities research analysts have also issued reports on the stock. Wells Fargo & Company […]
